InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Kulkarni Samarth, Chairman & CEO. Insider active across 1 company, notably CRISPR Therapeutics AG. In total, 51 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €3.9m. Activity tracked since 1 June 2021. The latest transaction was filed on 20 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kulkarni Samarth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations51 total
19,687 sharesCommon SharesSEC:0001193125-26-122272:0
20,625 sharesCommon SharesSEC:0001193125-26-111278:0
19,250 sharesCommon SharesSEC:0001193125-26-104480:0
13,250 sharesCommon SharesSEC:0001193125-26-061712:0
21,433 shares@ US$51.618.1% of flowCommon SharesSEC:0001193125-26-019733:0
30,000 shares0Common SharesSEC:0001193125-25-329010:0
100,000 sharesCommon SharesSEC:0001193125-25-243819:0
8,334 sharesCommon SharesSEC:0001193125-25-240438:0
6,000 shares0Common SharesSEC:0001193125-25-209353:0
25,000 sharesCommon SharesSEC:0001682019-25-000003:0
19,688 sharesCommon SharesSEC:0000950170-25-043975:0
19,250 sharesCommon SharesSEC:0000950170-25-038216:0
18,360 shares@ US$55.2058.5% of flowCommon SharesSEC:0000950170-25-025000:0
13,250 sharesCommon SharesSEC:0000950170-25-023385:0
13,751 shares@ US$16.211.9% of flowCommon SharesSEC:0000950170-24-140846:0
15,000 shares@ US$55.10436.8% of flowCommon SharesSEC:0000950170-24-133373:0
23,121 shares@ US$55.4310.4% of flowCommon SharesSEC:0000950170-24-126521:0
8,333 sharesCommon SharesSEC:0000950170-24-114786:0
100,000 shares0Common SharesSEC:0000950170-24-095615:0
19,582 shares@ US$19.123.1% of flowCommon SharesSEC:0000950170-24-045196:0
20,000 shares@ US$19.123.1% of flowCommon SharesSEC:0000950170-24-032989:0
19,250 sharesCommon SharesSEC:0000950170-24-030189:0
13,250 sharesCommon SharesSEC:0000950170-24-018174:0
20,000 shares@ US$19.123.1% of flowCommon SharesSEC:0000950170-24-016574:0
50,000 shares@ US$19.127.7% of flowCommon SharesSEC:0000950170-24-009505:0
25 of 51 declarations
About Kulkarni Samarth
Kulkarni Samarth is Président-Directeur Général and Chief Executive Officer at CRISPR Therapeutics AG. Across 51 total filings, the 51 sampled filings cover the period from 2021-06-03 to 2026-03-24, with 0 EUR of buys and 3900377 EUR of sells, and the most common transaction nature is Levée d'options.
